Norges Bank’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Buy |
+687,662
| New | +$11M | ﹤0.01% | 1260 |
|
|
2025
Q1 | – | Sell |
-637,947
| Closed | -$15.8M | – | 800 |
|
|
2024
Q4 | $15.8M | Buy |
+637,947
| New | +$15.8M | ﹤0.01% | 1269 |
|
|
2024
Q3 | – | Sell |
-601,861
| Closed | -$15.9M | – | 823 |
|
|
2024
Q2 | $15.9M | Sell |
601,861
-54,239
| -8% | -$1.43M | ﹤0.01% | 1269 |
|
|
2024
Q1 | $21.2M | Buy |
656,100
+617,659
| +1,607% | +$20M | ﹤0.01% | 1246 |
|
|
2023
Q4 | $1.62M | Buy |
+38,441
| New | +$1.62M | ﹤0.01% | 1815 |
|
|
2023
Q1 | – | Sell |
-211,600
| Closed | -$3.76M | – | 2127 |
|
|
2022
Q4 | $3.76M | Sell |
211,600
-8,301
| -4% | -$147K | ﹤0.01% | 1859 |
|
|
2022
Q3 | $1.23M | Buy |
219,901
+190,435
| +646% | +$1.06M | ﹤0.01% | 1990 |
|
|
2022
Q2 | $115K | Hold |
29,466
| – | – | ﹤0.01% | 2046 |
|
|
2022
Q1 | $162K | Hold |
29,466
| – | – | ﹤0.01% | 2149 |
|
|
2021
Q4 | $251K | Hold |
29,466
| – | – | ﹤0.01% | 2185 |
|
|
2021
Q3 | $256K | Sell |
29,466
-408,300
| -93% | -$3.55M | ﹤0.01% | 2256 |
|
|
2021
Q2 | $4.63M | Buy |
437,766
+241,323
| +123% | +$2.55M | ﹤0.01% | 1918 |
|
|
2021
Q1 | $3.15M | Buy |
196,443
+182,074
| +1,267% | +$2.92M | ﹤0.01% | 1959 |
|
|
2020
Q4 | $664K | Buy |
+14,369
| New | +$664K | ﹤0.01% | 2064 |
|